News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Jacques Rachelle Suzanne
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/01/2023 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Sold 384 shares
@ $20.02, valued at
$7.7k
|
|
06/17/2022 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Granted 9,080 shares
@ $0 Granted 17,810 options to buy
@ $14.08, valued at
$250.8k
|
|
05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/22/2021 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on uniQure N.V.
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2020 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Viela Bio, Inc.
Txns:
| Granted 14,716 options to buy
@ $48.96, valued at
$720.5k
|
|
05/22/2020 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Granted 40,500 options to buy
@ $7.3, valued at
$295.7k
|
|
06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2019 |
4
| Jacques Rachelle Suzanne (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Granted 68,000 options to buy
@ $7.8, valued at
$530.4k
|
|
|
|